Adebrelimab and Chemoradiotherapy in High-risk LANPC

Clinical trial NCT06349889 · RECRUITING

Trial details

NCT number: NCT06349889
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma Nasopharyngeal Cancer

Start date: 2024-07-23
Primary completion: 2028-05-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.